Observational Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jul 16, 2024; 12(20): 4217-4229
Published online Jul 16, 2024. doi: 10.12998/wjcc.v12.i20.4217
Figure 1
Figure 1 Related research routes. MHD: Maintenance hemadialysis; PH: Pulmonary hypertension.
Figure 2
Figure 2 Systolic pulmonary artery pressure (A) and arterial partial oxygen pressure (B) indicators for both groups. aP < 0.05 and eP<0.001 vs the same group before treatment; fP < 0.001 vs group C. SPAP: Systolic pulmonary artery pressure; PaO2: Arterial partial oxygen pressure.
Figure 3
Figure 3 Pulmonary vascular resistance (A) and blood oxygen saturation (B) indicators for both groups. aP < 0.05 and eP < 0.001 vs the same group before treatment; fP < 0.001 vs group C. PVR: Pulmonary vascular resistance; SaO2: Blood oxygen saturation.
Figure 4
Figure 4 6-minute walk distance test indicators (A) and Borg scores (B) for two groups. bP < 0.01 and eP < 0.001 vs the same group before treatment; cP < 0.05 and dP < 0.01 vs group C. 6MWD: 6-minute walk distance test.